Clinical Trials Logo

Filter by:
NCT ID: NCT05774756 Enrolling by invitation - Clinical trials for Hypothalamic Obesity

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Start date: April 26, 2023
Phase: Phase 3
Study type: Interventional

The goal of this trial is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years of age and older with acquired Hypothalamic Obesity (HO). To determine how well setmelanotide works and how safe it is, patients with HO will take a daily injection of either setmelanotide or placebo and complete trial assessments for up to 60 weeks.

NCT ID: NCT05773495 Enrolling by invitation - Clinical trials for Diabetic Retinopathy

Implementation of Teleophthalmology in Urban Health Systems Study

Start date: March 19, 2024
Phase: N/A
Study type: Interventional

This study is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in urban, multi-payer health systems.

NCT ID: NCT05770479 Enrolling by invitation - Clinical trials for Mild Cognitive Impairment

Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans

AID-CCT
Start date: July 1, 2023
Phase: N/A
Study type: Interventional

Veterans have numerous risk factors (e.g., PTSD, TBI, cerebrovascular problems) for later-life cognitive and functional decline. Evidence supports the effectiveness of strategy-based cognitive rehabilitation therapies, including compensatory cognitive training (CCT), for such decline. However, questions remain about the length of time that CCT-driven improvements in cognitive and everyday function last, and whether additional 'booster' training sessions could provide additional benefit to aging Veterans who previously underwent treatment. This study examines the long-term durability of CCT in Veterans aged 55+ and provides an opportunity to develop and pilot test a series of CCT booster sessions that can be personalized toward individual everyday functional goals.

NCT ID: NCT05769023 Enrolling by invitation - COVID-19 Clinical Trials

A Spatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Conduct a study of people who use drugs (PWUD) perceptions of and access to COVID-19 vaccines as well as reasons for vaccine hesitancy/barriers

NCT ID: NCT05768386 Enrolling by invitation - Hemophilia A Clinical Trials

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

GENEr8-LTE
Start date: January 1, 2023
Phase:
Study type: Observational

The BMN 270 clinical development program consists of multiple interventional studies designed to assess the safety and efficacy of a single infusion of BMN 270 for at least 5 years post-infusion. This long-term follow-up study is needed to help further understand the long-term safety of BMN 270 beyond 5 years and to assess the durability of efficacy.

NCT ID: NCT05767996 Enrolling by invitation - Clinical trials for Familial Hyperlipidemia

School-based Education and Screening Program With Lipid Screening as a Means to Identify Familial Hyperlipidemia

Start date: February 1, 2023
Phase:
Study type: Observational

Determination of FH status by genetic testing in school age children who have demonstrated elevated cholesterol on baseline screening.

NCT ID: NCT05766956 Enrolling by invitation - Acute Illness Clinical Trials

Effect of Advanced Care at Home vs. Traditional Brick-and-Mortar Hospital Care in Acutely Ill Adults: A Pragmatic Clinical Trial

Start date: July 10, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to compare two care delivery models that are currently being implemented in routine practice settings. The findings from this study will inform future clinical decision making, such as which patients might be more suited for which care delivery model.

NCT ID: NCT05764642 Enrolling by invitation - Healthy Clinical Trials

A Study of Renal Microvessel Imaging for Chronic Kidney Disease

Start date: August 9, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.

NCT ID: NCT05764213 Enrolling by invitation - Clinical trials for Substance Use Disorders

Improving Maternal Mental Health & SUD Screening and Treatment

Start date: April 3, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to compare a text message-based mental health and substance use screening and referral to a treatment program, called Listening to Women and Pregnant and Postpartum People (LTWP), to standard of care in-person mental health and substance use screening to look at rates of treatment attendance and retention in treatment. Participation would involve completing online questionnaires. You may be eligible to participate if you are age 18-45 years, are pregnant and entering prenatal care in one of MUSC's OB clinics, and attended a prenatal appointment at an MUSC clinic.

NCT ID: NCT05763667 Enrolling by invitation - Post Operative Pain Clinical Trials

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Start date: January 1, 2024
Phase: Phase 3
Study type: Interventional

Modern postoperative pain management aims to optimizing pain relief while minimizing opiate usage. While opiates are effective for pain relief, they result in common adverse effects such as nausea, constipation, and urinary retention, and most importantly present a long-term risk of abuse and dependency. Commonly used approaches include non-opiate pain medications such as acetominophen and non-steroidal anti-inflammatory agents, as well as regional nerve blocks such as epidurals. The transversus abdominis plane (TAP) block is a fascial plane block performed by injecting local anesthetic into the plane superficial to the transversus abdominis muscle where the anterior rami of the spinal nerves course to provide sensory innervation to the abdominal wall. The injections are generally placed either subcostally or at the midaxillary line bilaterally. The TAP block has been shown to be effective in reducing pain scores and opiate usage in some randomized studies but not others in patients undergoing various abdominal surgeries. There is great variation in method of administration, sites injected, and local anesthetics used, which may in part account for the heterogeneity of trial results.